Luk Vandenberghe, PhD

The AAVCOVID vaccine program, a novel gene-based vaccine strategy led by Luk Vandenberghe, PhD, Associate Professor of Ophthalmology at Harvard Medical School and Director of the Grousbeck Gene Therapy Center at Mass Eye and Ear, that utilizes an adeno...

On June 13, Harvard Ophthalmology hosted a successful reimagined Annual and Alumni Virtual Meeting with nearly 300 faculty and alumni attendees. With a central theme of I nnovation and Adaptation During COVID-19 and Beyond, the event focused on the...

Researchers led by a team at Massachusetts Eye and Ear have identified a novel cellular entry factor for adeno-associated virus vector (AAV) types—the most commonly used viral vectors for in vivo gene therapy. AAVs are vectors–or vehicles—that are created...

Luk H. Vandenberghe, PhD , Harvard Medical School Associate Professor of Ophthalmology and Director of the Grousbeck Gene Therapy Center at Mass. Eye and Ear, has been named the first incumbent of the Grousbeck Family Chair in Gene Therapy at Mass. Eye...

In Nature, Luk Vandenberghe, PhD, Harvard Medical School Associate Professor of Ophthalmology and Director of the Grousbeck Gene Therapy Center at Mass. Eye and Ear, discusses increasing the efficiency of gene therapies by manipulating the viral vectors...

Luk Vandenberghe, PhD , Director of the Grousbeck Gene Therapy Center at Mass. Eye and Ear and Assistant Professor of Ophthalmology at Harvard Medical School, will receive the American Society of Gene and Cell Therapy (ASGCT) Outstanding New Investigator...

New nonprofit organization will bring treatments to clinical trial for people at risk for blindness due to ultra-rare inherited retinal diseases. Boston, Mass. — Scientists and advocates today announced the formation of Odylia Therapeutics, a nonprofit...

Luk H. Vandenberghe, PhD, along with collaborator and lead author Rob Collin, PhD, of Radboud University Medical Center, has been selected to receive the 2017 Ed Gollob Board of Directors’ Award from the Foundation Fighting Blindness (FFB). This award is...

Improved delivery vector better penetrates the inner ear, also restores balance in a mouse model of Usher syndrome Boston, Mass. — In the summer of 2015, a team at Boston Children’s Hospital and Harvard Medical School reported restoring rudimentary...

Boston, Mass. — Luk H. Vandenberghe, PhD, Director of the Grousbeck Gene Therapy Center at Massachusetts Eye and Ear and an Assistant Professor of Ophthalmology at Harvard Medical School, has been awarded a Nelson Trust Award for Retinitis Pigmentosa by...